Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Study Information
Alliance Study ID: CALGB-9270
NCT Study ID (ClinicalTrials.gov): NCT00002527
Alliance Committee: Cancer Control
Disease or Cancer Type: Colorectal / Colon / Rectal Cancer
Alliance Study Chair: Robert Sandler, MD, MPH
Status: COMPLETED
Study Description
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of aspirin may be an effective way to prevent the recurrence of polyps in colorectal cancer.
PURPOSE: Randomized phase III trial to study the effectiveness of aspirin in treating patients who have stage I, stage II, or stage III colorectal cancer that has been surgically removed.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information